We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » HeartWare Lands Warning Letter For Validation, CAPA Concerns
HeartWare Lands Warning Letter For Validation, CAPA Concerns
Coronary device company HeartWare International said Wednesday that it received an FDA warning letter related to the company’s Miami Lakes, Fla., manufacturing facility.